Patent ductus arteriosus (PDA) occurs in nearly 50% of preterm infants born at ,32 weeks' gestation. 1 The PDA shunts blood away from the descending aorta into the pulmonary artery, resulting in systemic hypoperfusion and pulmonary overcirculation. 2, 3 It is considered a significant precursor to mortality and morbidity in extremely preterm neonates, including congestive heart failure, intraventricular hemorrhage (IVH), necrotizing enterocolitis (NEC), prolonged ventilator dependency, and chronic lung disease (CLD). 1, 4 Methods to close or minimize the effects of a clinically significant PDA include conservative management (eg, fluid restriction, diuretics, ventilation strategies), cyclooxygenase inhibitors (eg, indomethacin or ibuprofen), acetaminophen, or surgical ligation. 5, 6 Surgical ligation is usually only considered when medical treatment has either failed or was contraindicated. 7 Several investigators have studied PDA ligation and its association with neonatal mortality, short-term morbidity, and neurodevelopmental impairment (NDI) in early childhood. Mirea et al 8 and Clyman et al 9 found increased retinopathy of prematurity (ROP) and CLD in infants treated with ligation compared with non-surgically treated infants. Two large studies found that extremely preterm infants who were treated with surgical ligation had significantly higher odds of NDI at 2-year follow-up, 10, 11 although a third study showed no increased risk. 12 In light of these concerns and somewhat conflicting results, the merits and safety of ligation have been questioned, with increasing uncertainty about appropriate patient selection and the optimal timing for surgery to minimize morbidity. [13] [14] [15] [16] This uncertainty has been associated with a secular trend toward a permissive approach to the PDA. [17] [18] [19] However, few of the studies performed to date have controlled for confounding by indication, that infants referred for surgical ligation may represent a more "ill" cohort and may be at higher risk of NDI. As a result, there is a paucity of relevant, reliable studies to guide the PDA ligation decision.
Our objective was to systematically review and meta-analyze the impact of PDA ligation in preterm infants at ,32 weeks' gestation on the risk of mortality, severe neonatal morbidities, and NDI.
METHODS
We conducted and reported this review following the Preferred Reporting Items for Systematic Reviews and Metaanalyses guidelines. 20 The protocol for this review was registered with PROS-PERO, the international prospective register of systematic reviews (http:// www.crd.york.ac.uk/NIHR_PROSPERO, identifier CRD42013005390).
Types of Studies
Randomized controlled trials (RCTs) and case-control or cohort studies with a comparator group were included if published in the form of an original research manuscript in a peerreviewed journal, an abstract in conference proceedings, or a dissertation. Narrative reviews, letters, editorials, and commentaries were excluded but read to identify potential studies. Duplicate reports not providing additional information were excluded. Crosssectional studies, case reports and series, qualitative studies, review articles, and studies that did not report methods were excluded but read to identify potential studies. Studies in infants with a PDA that did not report on outcomes in infants who underwent surgical ligation were excluded.
Types of Participants
Preterm infants born at a gestational age (GA) ,32 weeks with a clinical and/or echocardiographic diagnosis of PDA were included. Studies in which some infants were born $32 weeks' GA were included if .80% of infants in the study population had a GA ,32 weeks. The diagnosis of PDA was made on the basis of clinical suspicion and/or echocardiography. Echocardiography diagnosis was preferable but not mandatory for inclusion in this review.
Exposure and Comparison
Studies must have included and compared, at a minimum, a surgically versus medically treated group or subgroup. Surgical subgroups included those infants treated with pharmacotherapy followed by surgical ligation ("pharmacotherapy and ligation" subgroup, indicating treatment with a nonsteroidal antiinflammatory drug [NSAID] or acetaminophen, followed by surgery) or those infants who underwent primary ligation ("primary ligation" subgroup, indicating surgical ligation without preceding pharmacotherapy). Medical subgroups included infants who received pharmacotherapy only ("pharmacotherapy only" subgroup, indicating treatment with NSAIDs or acetaminophen but not surgery) and those treated without surgery or pharmacotherapy ("conservative" subgroup). Conservative management referred only to watchful observation and the use of fluid restriction, diuretics, digoxin, and/or mechanical ventilation adjustment to manage the PDA shunt but excluded NSAID/acetaminophen and surgical treatments. Infants in the surgical or pharmacotherapy groups may have been treated with conservative measures initially before their respective definitive treatment.
Surgical ligation must have been performed before 40 weeks' corrected GA, either at the bedside or in the operating room, via a left lateral thoracotomy using a clip or ligature and not in conjunction with another surgery.
Outcomes
Studies were included if they reported at least 1 of the following outcomes for any treatment groups or subgroups: Studies were included if neonatal or neurodevelopmental outcomes were complete for $90% and $75% of the cohort, respectively. A lower neurodevelopmental follow-up rate ($70%) was accepted if infants lost to follow-up were described in detail and comparable to the cohort with known outcomes.
Review Methods

Search Strategy
The search strategy was designed with the assistance of an information scientist. We searched the following databases without language restriction: Medline (1948 through August 
Data Extraction
Two authors (D.E.W. and K.M.) independently conducted the literature search. Information about study inclusion, study design, key characteristics, and outcomes was extracted independently by the 2 reviewers using a standardized data collection form. Discrepancies were resolved by consensus or by involving a third author (P.S.S.). Authors were contacted for clarifications and/or additional data.
Assessment of Risk of Bias
For randomized studies, we used the Cochrane Handbook Risk of Bias assessment tool. 26 Studies were included if they had a low or moderate risk of bias. For observational studies, the risk of bias was assessed by using the information in the original publications, and included evaluation for selection (representative cohort or selected population), exposure assessment, outcome assessment, attrition, and confounding factor biases by using a modified Newcastle-Ottawa Scale, 27 which was altered to reflect 2 different follow-up periods (neonatal and neurodevelopmental follow-up) and a focus on confounding by indication (Supplemental Information 2). Studies were included if they scored at least 6 (of 10 stars) on this modified NewcastleOttawa Scale.
We identified, a priori, that the use of surgical ligation as a "rescue" treatment after failure of medical therapy potentially imparts 2 important sources of bias. First, it may result in survival bias, because infants initially treated medically must have survived to be eligible for ligation. Second, it may result in confounding by indication, where ligated infants may be more likely to have increased pretreatment morbidity. Infants with higher illness severity after failed medical treatment, characterized by, for example, NEC, hypotension, or dependence on mechanical ventilation, may have been more likely to be referred for ligation. Included studies were therefore descriptively evaluated on how they adjusted for postnatal confounders at the time of the decision to treat the PDA.
The risk of bias assessment was performed independently by 2 authors (D.E.W. and K.M.). Differences of opinion were resolved by discussion and involvement of a third author (P.S.S.).
Data Synthesis and Statistical Analysis
Unadjusted and adjusted data were respectively combined in randomeffects model meta-analyses (Review Manager 5.2; Cochrane Collaboration, Nordic Cochrane Centre, Copenhagen, Denmark). 28 Meta-analyses were performed comparing all groups and subgroups based on the data presented in the included studies. The meta-analyses of adjusted data only included studies that had, at a minimum, controlled for GA. Similar to other meta-analyses, no adjustment for multiple analyses was made. Study weight in the meta-analyses was calculated by using the generic inverse variance method. This method assigns greater weight to larger studies (which have smaller SEs) and minimizes the imprecision of the pooled effect estimate. The random-effects model was selected to account for variability between and within studies because we anticipated a degree of clinical and statistical heterogeneity. Because all outcomes were binary, odds ratios with 95% confidence intervals (CIs) were used to report differences between groups. Data from studies that reported both adjusted and unadjusted risks in their population were used in the respective meta-analyses. It was anticipated that not all studies would have accounted for similar confounders in their adjustment, and we obtained information on the covariates used. Adjusted odds ratios (aORs) were converted to log odds and then meta-analyzed.
Heterogeneity and Publication Bias Assessment
Clinical heterogeneity was assessed and reported in the table of included studies (Table 1) by describing the populations included, treatment groups compared, and confounders adjusted. Statistical heterogeneity was assessed and reported by using the I 2 statistic. 29 Sources of heterogeneity were sought if I 2 was .50%.
RESULTS
Description of Studies
The results of the search, the study selection log, and the number of studies are reported in Fig 1. One hundred twenty-three articles were reviewed in detail. Primary authors were contacted to obtain additional information, as needed. Six authors provided additional data or analyses not included in their original publication. 8, [30] [31] [32] [33] [34] Baseline characteristics of the 40 studies included 8, 10, 11, (39 cohort studies and 1 RCT), encompassing 32 345 preterm infants, are reported in Table 1 .
Eighty-three studies were excluded; 63 studies were excluded because they did not report sufficient data to compare outcomes of treatment assignment groups or subgroups. 9, 17, Five studies were excluded because they were a review or an editorial. [128] [129] [130] [131] [132] Three studies were excluded because they represented cohorts already accounted for in another included study. [133] [134] [135] Ten studies were excluded because .20% of infants in the cohort were $32 weeks' GA. [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] Two studies were excluded because the cohort and analysis included all admitted infants rather than only infants with a PDA. 12, 146 NSAIDs (ibuprofen or indomethacin) were the only pharmacologic therapies used.
Twenty-eight of the 39 included cohort studies performed treatment group comparisons without adjustment for covariates, and these data were pooled only in the meta-analyses of univariate results. Eleven cohort studies performed multivariate analyses. Data from 9 of these studies 8, 10, 11, 30, 33, 51, 58, 63, 64 and the RCT 35 were combined in meta-analyses of multivariate results. Data from 2 cohort studies 32, 34 could not be pooled because of insufficient information to interpret the adjusted results. Meta-analyses were performed comparing all treatment group and subgroup combinations when data were provided in the included studies ( Table 2) .
Risk of Bias Among Included Studies
The risk of bias among cohort studies is reported in REVIEW ARTICLE study adjusted for postnatal preligation confounders, by controlling for IVH, hypotension, and a PDA-related illness severity score measured at the time of the decision to treat the PDA. 58 The possibility of survival bias was not addressed by any cohort study.
Main Results
Meta-analyses of univariate and multivariate results for all treatment group and subgroup comparisons are presented in Table 2 . The outcomes for ligated compared with medically treated infants are as follows:
1. Death before discharge from the NICU: a meta-analysis of studies that reported an adjusted risk of death revealed that infants who underwent surgical ligation had lower odds of death compared with those infants who were treated medically (5 studies, 7159 participants; pooled aOR: 0.54; 95% CI: 0.38-0.77; I 2 = 39%) (Fig 2A, Table 2 ). The association between ligation and decreased mortality was seen across all subgroup comparisons (Fig 2 B-D, Table 2 ).
CLD: meta-analysis revealed that
surgical ligation was associated with higher odds of CLD compared with medical management alone (4 studies, 6703 participants; pooled aOR: 2.51; 95% CI: 1.98-3.18; I 2 = 44%) ( Fig 3A, Table 2 ).
3. Severe ROP: meta-analysis revealed that surgical ligation was associated with higher odds of severe ROP compared with medical management alone (3 studies, 3122 participants; pooled aOR: 2.23; 95% CI: 1.62-3.08; I 2 =37%) ( Fig 4A, Table 2 ).
4. NDI in early childhood: metaanalysis revealed that NDI was higher among infants who underwent surgical ligation compared with those treated medically (3 studies, 3250 participants; pooled aOR: 1.54; 95% CI: 1.01-2.33; I 2 = 48%) ( Fig 5A, Table 2 ). There was a trend toward higher NDI among infants treated with NSAIDs and ligation compared with infants treated with NSAIDs alone (2 studies, 2441 participants; aOR: 1.39; 95% CI: 0.97-1.98; I 2 = 29%) ( Fig  5B, Table 2 Table 2 ). Most of the statistical heterogeneity between these 4 studies is accounted for by 1 study, 58 which was the only study to report a significant protective effect of surgical ligation. Importantly, this study was also the only one in this review to control for confounding by indication. 6. Cognitive impairment: only 1 study 11 reported an adjusted estimate of cognitive impairment and found increased odds associated with ligation compared with medical management alone (331 participants; aOR: 1.96; 95% CI: 1.14-3.37) ( Table 2 ).
7. Cerebral palsy: meta-analysis revealed that there was no difference in the odds of cerebral palsy 11, 63 between those who underwent surgical ligation and those treated medically (2 studies, 616 participants; pooled aOR: 1.51; 95% CI: 0.86-2.63; I 2 = 0%) ( Fig 5C, Table 2 ).
DISCUSSION
In this systematic review and metaanalysis of the effects of PDA treatment assignment on neonatal and neurodevelopmental outcomes, we identified that surgical ligation is associated with decreased mortality but increased NDI in early childhood when compared with medical treatment alone. There are several possible explanations for the divergence of these competing outcomes: first, surgical ligation may improve the survival of infants but be simultaneously neurologically detrimental; second, surgical ligation may improve the survival of infants, but infants referred for ligation may be at higher preligation risk of NDI (confounding by indication); and finally, the decrease in mortality may be influenced by survival bias (where medically treated infants with a PDA die before being referred for ligation), with the increase in NDI explained by either confounding by indication or a true detrimental effect of ligation.
Several aspects of treatment with ligation have been proposed as contributing to an increased risk of NDI, such as surgical or anesthesia effects or postoperative hemodynamic compromise. Early surgical mortality associated with PDA ligation is reported to be low. 49, 56, 66 Direct surgical morbidities include bleeding, pneumothorax, and left vocal cord paresis (VCP). The incidence of left VCP is variable but may complicate 5% to 50% of PDA ligations and is associated with an increased risk of death, extubation failure, CLD, need for gastrostomy tube, and gastroesophageal reflux disease. 66, [147] [148] [149] Recent studies have reported an association between the use of halothane gases for anesthesia in young children and NDI. 150, 151 Preterm infants are at risk of postligation hemodynamic instability, which may result in cerebral hypoperfusion, neuronal injury, and subsequent NDI. [152] [153] [154] [155] [156] [157] In our review, only 1 of the included studies 30 reported on an association of VCP and NDI, and no study described an association between postligation hemodynamic 
FIGURE 6
Adjusted estimate of the composite outcome of death or NDI in early childhood: All Ligation versus All Medical Management only. df, degrees of freedom; IV, inverse variance; Mgmt, management.
instability and NDI. Infants with lower GA and weight ,1 kg at the time of ligation are at highest risk of postligation hemodynamic instability, possibly due to decreased myocardial adaptability to altered loading conditions. 158 This finding raises the possibility that age at ligation may contribute to the risk of NDI; however, a post hoc analysis of the Trial of Indomethacin Prophylaxis in Preterm Infants found no association between the timing of PDA ligation and the risk of NDI. 11 Despite the reported association between ligation and NDI, observational studies to date have not adequately differentiated the effect of bias versus a true detrimental effect of ligation. In general, observational studies are subject to bias when treatment assignment is not independent of baseline prognostic factors. Many of the included studies did not perform any adjustment forconfounders. Infants who underwent surgical ligation of their PDA had significantly different baseline characteristics compared with their medically treated peers, with generally lower GA and birth weight ( Table 1) . The presence of these major confounders limits the validity of unadjusted comparisons. In addition, most of the multivariate analyses included in this review only adjusted for antenatal or perinatal covariates (Table 1 ). This set of covariates, if complete, would be sufficient to balance baseline prognostic factors for interventions that occur shortly after birth. However, PDA ligation often occurs several weeks after birth, and the interval accumulation of PDAassociated comorbidities influences both treatment assignment and outcomes.
The most important source of bias in the included multivariate studies is confounding by indication, in which infants with higher illness severity, who may be at higher risk of NDI, 159,160 may be more likely to be assigned to ligation. Only 1 study 58 adjusted for preligation postnatal confounders, such as IVH or the duration/intensity of mechanical ventilation at the time of the decision to treat the PDA. In the setting of surgical ligation, severe IVH is a potential confounder. It has been associated with PDA ligation 45, 52, 62 and NDI [161] [162] [163] [164] [165] and is not typically on the causal pathway between PDA ligation and NDI. Most IVH (90%) occurs in the first week of life, 166 preceding the timing of surgical ligation reported in most studies. 33, 45, 48, 50, 59 Other potential key confounders include prolonged duration of mechanical ventilation, severe hypotension, postnatal sepsis, and NEC, which increase illness severity but are also associated with PDA ligation, death, NDI, CLD, and ROP. [167] [168] [169] [170] [171] [172] [173] [174] [175] These morbidities, however, can occur before, during, or after PDA treatments and thus may be considered confounders in some infants and outcomes in others. Therefore, data on the timing of these confounders relative to ligation should be incorporated into multivariable models examining the impact of surgical treatment.
The lower mortality in the ligated group may be attributable, in part, to survival bias. The PDA treatment algorithms in many of the included studies (Table 1) cited that infants were treated with ligation when indomethacin failed or was contraindicated. Ligation was often undertaken later in life relative to medical therapy, meaning that ligated infants were more likely to have already survived the period of high early neonatal mortality. This implies that some of the sickest infants, treated initially with conservative management and/or indomethacin, may have died before becoming "eligible" for ligation, resulting in selection bias in assembling the cohort of ligated infants. This issue was present in most of the cohort studies, and thus our findings of decreased mortality should be interpreted with caution. Future studies that compare surgical ligation with medical therapy should ensure careful matching of the control population with consideration of age at ligation.
The possibility of survival bias is supported by findings of the subgroup meta-analyses. Survival bias associated with ligation would be expected to manifest as an apparent survival advantage when ligation is performed later in life, but that ligation performed at a similar day of life as medical therapy would have similar mortality rates. We found that infants treated with NSAIDs and ligation had lower adjusted odds of death compared with infants who underwent treatment with primary ligation, NSAIDs alone, or conservative management (Table 3) . In studies in which ligation was performed early in life (either as primary therapy or immediately after failure of indomethacin in the first week of life), there was no difference in mortality compared with medically treated infants. 12, 84 If ligation truly improved survival (and survival bias was not a factor), then a reduction in rates of surgical treatment might be expected to increase mortality, assuming that the clinical characteristics of infants remained the same. Two studies 14, 17 reported no change in mortality across epochs after moving to a delayed selective ligation strategy from an early routine ligation strategy after indomethacin failure. However, other studies have reported an increase in mortality when surgical ligation was no longer available 176 and when ligation was not performed in infants with a persistent PDA after failure of medical therapy. 177 This finding suggests that both survival bias and a true survival benefit of surgical ligation may be present.
We found that infants exposed to PDA ligation also had increased CLD and severe ROP. This is biologically supported by the potential cardiorespiratory instability and inflammatory effects associated with surgical ligation [178] [179] [180] and was shown in a secondary analysis of an RCTof early prophylactic ligation in extremely low birth weight infants. 9, 77 Given its association with NDI, this risk of CLD may represent a plausible pathway for the increased NDI associated with ligation. [181] [182] [183] Nonetheless, confounding by indication remains an important source of bias in these studies as well. Only 1 study controlled for postnatal sepsis, 10 a known risk factor for CLD, 184 and this study did not differentiate between sepsis that occurred before or after surgical ligation. In addition, ventilator dependence is commonly considered an indication for ligation in infants in whom medical therapy had failed or was contraindicated, 33, 44, 47, 48, 62 and yet it is also a risk factor for CLD. 185 Given the association between CLD and ROP and death or NDI, 181, 182, 186 it is important, when analyzing these outcomes, to adjust for preligation respiratory morbidity.
Conclusions and Implications
This systematic review and meta-analysis identified an association between PDA ligation and decreased odds of death;
increased odds of CLD, ROP, and NDI in early childhood; and no difference in the composite outcome of death or NDI. However, this association comes predominantly from observational studies thatinadequatelyaddressedsurvivalbias and confounding by indication. Many of these studies also lacked standardized echocardiographic and clinical criteria to define a hemodynamically significant PDA. Our review highlights the difficulty faced by clinicians considering surgical ligation. The clinician must navigate literature that reports an association with significant morbidity, albeit fraught with methodologic biases and clinical uncertainty regarding patient selection and the optimal timing for surgery.
This study provides direction to improve the available evidence to guide clinicians about the PDA ligation decision. Whereas an RCT examining 2 different PDA treatment protocols would be instructive, the variability in practice among centers may reduce the external validity of such a trial. Observational studies are therefore needed that adjust for preligation time-dependent covariates to fully elucidate the effects of PDA ligation.
Strengths and Limitations
This review encompasses a comprehensive search and explicit inclusion and exclusion criteria and poses clinically important questions. There was low to moderate clinical and statistical heterogeneity in most studies included in this review. This meta-analysis is limited by a paucity of studies that performed multivariate analyses and the insufficiency of these studies in addressing survival bias and confounding by indication for postnatal morbidities, such as ventilator dependence, IVH, sepsis, or NEC, that occurred before treatment with surgical ligation.
